Compared to cells transfected with control siRNAs, MLL-AF4 mRNA expression was reduced to 45% and 37% in the t(4;11)-positive ALL cell lines RS4;11 and SEMK2, respectively, upon transfection with siRNAs directed against MLL-AF4. The gene discussed is KMT2A; the disease is acute lymphoblastic leukemia.